Office of the Director, National Institutes of Health; Notice of Meeting, 87593-87594 [2024-25584]
Download as PDF
<![CDATA[
87593
Federal Register / Vol. 89, No. 213 / Monday, November 4, 2024 / Notices
and by whom, who gets evaluated, and
who gets placed on the organ
transplantation waiting list. These data
will also facilitate the OPTN’s ability to
address disparities in processes of care,
improve access to organ transplantation,
and assess overall system performance.
Once this collection is approved,
HRSA will cease the use of the Death
Notification Registration and the
Deceased Donor Death Referral forms
that are included within the existing
OMB-approved Data System for Organ
Procurement and Transplantation
Network OMB No. 0915–0157. This
decision was made to avoid unnecessary
burden and redundancy in the data
collected by this package and the
existing OMB data collection
instrument.
Likely Respondents: Transplant
Centers, OPOs, and Histocompatibility
Laboratories.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose, or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Pre-Waitlist Transplant Referral Form .............
Pre-Waitlist Transplant Evaluation Form .........
Ventilated Patient Form ...................................
248
248
56
1,164.68
594.22
3,292.00
288,840.64
147,366.56
184,352.00
0.35
0.40
0.50
101,094.22
58,946.62
92,176.00
..........................................................................
552
........................
620,559.20
....................
252,216.84
Form name
1 .....................
2 .....................
3 .....................
Total ........
The average burden estimates of both
new pre-waitlist forms are based on the
2023 burden estimates of existing OMBapproved Transplant Candidate
Registration forms, approved under
0915–0157. The average burden
estimate of the Ventilated Patient Form
is based on the average burden estimate
of the 2024 burden estimates of existing
OMB-approved Death Notification
Registration form with an additional
0.08 hour per collected form burden to
reflect an increase in total data fields.
HRSA specifically requests comments
on: (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions; (2) the accuracy of the
estimated burden; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Amy P. McNulty,
Deputy Director, Executive Secretariat.
[FR Doc. 2024–25522 Filed 11–1–24; 8:45 am]
lotter on DSK11XQN23PROD with NOTICES1
BILLING CODE 4165–15–P
VerDate Sep<11>2014
Average
burden per
response
(in hours)
Number of
respondents
Form No.
17:28 Nov 01, 2024
Jkt 265001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Advisory Committee to
the Director, National Institutes of
Health.
This will be a hybrid meeting held inperson and virtually and will be open to
the public as indicated below. Given the
capacity constraints of the venue, the
public is strongly encouraged to attend
virtually via NIH videocast. Individuals
who plan to attend in-person or view
the virtual meeting and need special
assistance or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting. The meeting can be
accessed from the NIH Videocast at the
following link: https://
videocast.nih.gov/.
Name of Committee: Advisory Committee
to the Director, National Institutes of Health.
Date: December 12, 2024.
Time: 9:00 a.m. to 5:45 p.m.
Agenda: NIH Director’s Report; Budget
Update; Legislative Update; RECOVER 2.0
Early Career Intramural Investigator
Highlight; ACD Working Group on Diversity
Update; Accessibility, Disability Inclusion,
and Disability Research at NIH; NExTRAC
ENGAGE Update; Scientific Management
Review Board. Other Business of the
Committee.
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
Total
responses
Total
burden
hours
Date: December 13, 2024.
Time: 9:00 a.m. to 12:15 p.m.
Agenda: Cancer Moonshot Update; ABCD
Update; Alzheimer’s Update; AMP Update
Other Business of the Committee.
Place: National Institutes of Health,
Building 1, Wilson Hall, One Center Drive,
Bethesda, MD 20892.
Contact Person: Cyndi Burrus-Shaw, Staff
Assistant, National Institutes of Health,
Office of the Director, One Center Drive,
Building 1, Room 126, Bethesda, MD 20892,
301–496–2433, email: shawcy@od.nih.gov.
Any interested person may file
written comments with the committee
by forwarding the statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/
about-nih/visitor-information/campusaccess-security for entrance into oncampus and off-campus facilities. All
visitor vehicles, including taxicabs,
hotel, and airport shuttles will be
inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal
facility will be asked to show one form
of identification (for example, a
government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
acd.od.nih.gov, where an agenda and
any additional information for the
meeting will be posted when available.
E:\FR\FM\04NON1.SGM
04NON1
87594
Federal Register / Vol. 89, No. 213 / Monday, November 4, 2024 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: October 30, 2024.
Bruce A. George,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–25584 Filed 11–1–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; Heart, Lung, and
Blood Program Project Study Section.
Date: December 6, 2024.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Address: North Bethesda Marriott Hotel &
Conference Center, Montgomery County
Conference Center Facility, 5701 Marinelli
Road, North Bethesda, MD 20852.
Meeting Format: In Person and Virtual
Meeting.
Contact Person: Melissa H. Nagelin, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health,
6705 Rockledge Drive, Room 208–R,
Bethesda, MD 20892, (301) 827–7951, email:
nagelinmh2@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
VerDate Sep<11>2014
17:28 Nov 01, 2024
Jkt 265001
Dated: October 30, 2024.
Bruce A. George,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF THE INTERIOR
Bureau of Land Management
[BLM_NV_FRN_MO4500183047]
[FR Doc. 2024–25585 Filed 11–1–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; International Research in
Infectious Diseases (R01 Clinical Trial Not
Allowed).
Date: December 2–3, 2024.
Time: 9:30 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Rockville, MD
20892.
Meeting Format: Virtual Meeting.
Contact Person: Rekha Dhanwani, Ph.D.,
Scientific Review Program, National Institute
of Allergy and Infectious Diseases, National
Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892, (240) 627–3076,
rekha.dhanwani@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: October 29, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–25549 Filed 11–1–24; 8:45 am]
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
Bureau of Land Management,
Interior.
ACTION: Notice of availability.
AGENCY:
National Institutes of Health
BILLING CODE 4140–01–P
Notice of Availability of the Proposed
Resource Management Plan
Amendment and Final Environmental
Impact Statement for the Rough Hat
Clark Solar Project in Clark County, NV
In compliance with the
National Environmental Policy Act of
1969, as amended (NEPA), and the
Federal Land Policy and Management
Act of 1976, as amended (FLMPA), the
Bureau of Land Management (BLM) has
prepared a Proposed Resource
Management Plan (RMP) Amendment
and Final Environmental Impact
Statement (EIS) for the Rough Hat Clark
Solar Project and by this notice is
announcing the start of a 30-day protest
period of the Proposed RMP
Amendment to the BLM Director.
DATES: This notice announces the
opening of a 30-day protest period for
the Proposed RMP Amendment. Protests
must be postmarked or electronically
submitted on the BLM’s National NEPA
Register site within 30 days of the date
that the Environmental Protection
Agency (EPA) publishes its Notice of
Availability (NOA) in the Federal
Register. The EPA usually publishes its
NOAs on Fridays.
ADDRESSES: The Proposed RMP
Amendment, Final EIS, and associated
documents are available on the BLM
National NEPA Register project website
at https://eplanning.blm.gov/eplanningui/project/2019992/510. Documents
pertinent to this proposal may also be
examined at the Southern Nevada
District Office, Las Vegas Field Office,
4701 N Torrey Pines Drive, Las Vegas,
Nevada 89130.
Instructions, including addresses, for
filing a protest with the BLM for the
Rough Hat Clark Solar Project can be
found at: https://www.blm.gov/
programs/planning-and-nepa/publicparticipation/filing-a-plan-protest and
at 43 CFR 1610.5–2.
FOR FURTHER INFORMATION CONTACT:
Jessica Headen, Project Manager,
telephone (702) 515–5206, address
Bureau of Land Management, 4701 N
Torrey Pines Drive, Las Vegas, NV
89130. Individuals in the United States
who are deaf, deafblind, hard of hearing,
or have a speech disability may dial 711
(TTY, TDD, or TeleBraille) to access
telecommunications relay services for
SUMMARY:
E:\FR\FM\04NON1.SGM
04NON1
]]>Agencies
[Federal Register Volume 89, Number 213 (Monday, November 4, 2024)]
[Notices]
[Pages 87593-87594]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-25584]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Advisory Committee
to the Director, National Institutes of Health.
This will be a hybrid meeting held in-person and virtually and will
be open to the public as indicated below. Given the capacity
constraints of the venue, the public is strongly encouraged to attend
virtually via NIH videocast. Individuals who plan to attend in-person
or view the virtual meeting and need special assistance or other
reasonable accommodations, should notify the Contact Person listed
below in advance of the meeting. The meeting can be accessed from the
NIH Videocast at the following link: https://videocast.nih.gov/.
Name of Committee: Advisory Committee to the Director, National
Institutes of Health.
Date: December 12, 2024.
Time: 9:00 a.m. to 5:45 p.m.
Agenda: NIH Director's Report; Budget Update; Legislative
Update; RECOVER 2.0 Early Career Intramural Investigator Highlight;
ACD Working Group on Diversity Update; Accessibility, Disability
Inclusion, and Disability Research at NIH; NExTRAC ENGAGE Update;
Scientific Management Review Board. Other Business of the Committee.
Date: December 13, 2024.
Time: 9:00 a.m. to 12:15 p.m.
Agenda: Cancer Moonshot Update; ABCD Update; Alzheimer's Update;
AMP Update Other Business of the Committee.
Place: National Institutes of Health, Building 1, Wilson Hall,
One Center Drive, Bethesda, MD 20892.
Contact Person: Cyndi Burrus-Shaw, Staff Assistant, National
Institutes of Health, Office of the Director, One Center Drive,
Building 1, Room 126, Bethesda, MD 20892, 301-496-2433, email:
[email protected].
Any interested person may file written comments with the committee
by forwarding the statement to the Contact Person listed on this
notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person.
In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for
entrance into on-campus and off-campus facilities. All visitor
vehicles, including taxicabs, hotel, and airport shuttles will be
inspected before being allowed on campus. Visitors attending a meeting
on campus or at an off-campus federal facility will be asked to show
one form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their visit.
Information is also available on the Institute's/Center's home
page: https://acd.od.nih.gov, where an agenda and any additional
information for the meeting will be posted when available.
[[Page 87594]]
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: October 30, 2024.
Bruce A. George,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-25584 Filed 11-1-24; 8:45 am]
BILLING CODE 4140-01-P
